92 related articles for article (PubMed ID: 2688231)
1. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
3. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases.
Boman G; Bäcker U; Larsson S; Melander B; Wåhlander L
Eur J Respir Dis; 1983 Aug; 64(6):405-15. PubMed ID: 6350033
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of inhaled corticosteroids in the management of non asthmatic chronic airflow obstruction.
Boothman-Burrell D; Delany SG; Flannery EM; Hancox RJ; Taylor DR
N Z Med J; 1997 Oct; 110(1053):370-3. PubMed ID: 9364183
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral N-acetylcysteine on mucus clearance.
Millar AB; Pavia D; Agnew JE; Lopez-Vidriero MT; Lauque D; Clarke SW
Br J Dis Chest; 1985 Jul; 79(3):262-6. PubMed ID: 3893512
[TBL] [Abstract][Full Text] [Related]
6. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
Brocard H; Charpin J; Germouty J
Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
[TBL] [Abstract][Full Text] [Related]
8. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis.
Rasmussen JB; Glennow C
Eur Respir J; 1988 Apr; 1(4):351-5. PubMed ID: 3294038
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
[TBL] [Abstract][Full Text] [Related]
10. No influence of acetylcysteine on gas exchange and spirometry in chronic asthma.
Bylin G; Hedenstierna G; Lagerstrand L; Wagner PD
Eur J Respir Dis; 1987 Aug; 71(2):102-7. PubMed ID: 3305057
[TBL] [Abstract][Full Text] [Related]
11. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
12. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study.
Eur J Respir Dis Suppl; 1980; 111():93-108. PubMed ID: 7011836
[No Abstract] [Full Text] [Related]
13. [Clinical results in the treatment of chronic obstructive bronchitis with ambroxol in comparison with bromhexine (author's transl)].
Wiessmann KJ; Niemeyer K
Arzneimittelforschung; 1978; 28(5a):918-21. PubMed ID: 373777
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.
Aylward M; Maddock J; Dewland P
Eur J Respir Dis Suppl; 1980; 111():81-9. PubMed ID: 7011835
[No Abstract] [Full Text] [Related]
15. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
16. [Peroral terbutaline in the treatment of patients with severe irreversible obstructive pulmonary disease].
Maltbaek N; Christensen HR; Garsdal P; Bro H; Rasmussen FV
Ugeskr Laeger; 1990 Mar; 152(11):729-32. PubMed ID: 2181755
[TBL] [Abstract][Full Text] [Related]
17. [The influence of n-acetylcysteine on chemiluminescence of granulocytes in peripheral blood of patients with chronic bronchitis].
Jankowska R; Passowicz-Muszyńska E; Medrala W; Banaś T; Marcinkowska A
Pneumonol Alergol Pol; 1993; 61(11-12):586-91. PubMed ID: 8148757
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
19. [Long-term atrovent treatment of chronic obstructive bronchitis].
Simanenkov VI; Il'iashevich IG; Liparteliani BG; Ledovaia AV
Ter Arkh; 1998; 70(9):77-9. PubMed ID: 9821235
[TBL] [Abstract][Full Text] [Related]
20. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease].
Ulrik CS
Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
